J 2021

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

MIKULKOVA, Zuzana, Gayane MANUKYAN, Peter TURCSANYI, Milos KUDELKA, Renata URBANOVA et. al.

Základní údaje

Originální název

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

Autoři

MIKULKOVA, Zuzana (203 Česká republika), Gayane MANUKYAN, Peter TURCSANYI, Milos KUDELKA (203 Česká republika), Renata URBANOVA (203 Česká republika), Jakub SAVARA (203 Česká republika), Eliska OCHODKOVA (203 Česká republika), Yvona BRYCHTOVÁ (203 Česká republika, domácí), Jan MOLINSKY (203 Česká republika), Martin SIMKOVIC (203 Česká republika), David STAROSTKA (203 Česká republika), Jan NOVAK (203 Česká republika), Ondrej JANCA (203 Česká republika), Martin DIHEL (203 Česká republika), Pavlina RYZNEROVA (203 Česká republika), Lekaa MOHAMMAD, Tomas PAPAJIK (203 Česká republika) a Eva KRIEGOVA (203 Česká republika, garant)

Vydání

Nature Scientific Reports, London, NATURE RESEARCH, 2021, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.996

Kód RIV

RIV/00216224:14110/21:00121640

Organizační jednotka

Lékařská fakulta

UT WoS

000627829300026

Klíčová slova anglicky

chronic lymphocytic leukaemia; complex circulating immune cell

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 5. 2021 14:25, Mgr. Tereza Miškechová

Anotace

V originále

The tissue microenvironment in chronic lymphocytic leukaemia (CLL) plays a key role in the pathogenesis of CLL, but the complex blood microenvironment in CLL has not yet been fully characterised. Therefore, immunophenotyping of circulating immune cells in 244 CLL patients and 52 healthy controls was performed using flow cytometry and analysed by multivariate Patient Similarity Networks (PSNs). Our study revealed high inter-individual heterogeneity in the distribution and activation of bystander immune cells in CLL, depending on the bulk of the CLL cells. High CLL counts were associated with low activation on circulating monocytes and T cells and vice versa. The highest activation of immune cells, particularly of intermediate and non-classical monocytes, was evident in patients treated with novel agents. PSNs revealed a low activation of immune cells in CLL progression, irrespective of IgHV status, Binet stage and TP53 disruption. Patients with high intermediate monocytes (>5.4%) with low activation were 2.5 times more likely (95% confidence interval 1.421-4.403, P=0.002) to had shorter time-to-treatment than those with low monocyte counts. Our study demonstrated the association between the activation of circulating immune cells and the bulk of CLL cells. The highest activation of bystander immune cells was detected in patients with slow disease course and in those treated with novel agents. The subset of intermediate monocytes showed predictive value for time-to-treatment in CLL.